• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量静脉注射依托泊苷后的血清和脑脊液水平

[Serum and cerebrospinal fluid levels after high dose of etoposide administrated intravenously].

作者信息

Kleisbauer J P, Lena-Nosny N, Vesco D

机构信息

Hôpital Salvator, Marseille, France.

出版信息

Bull Cancer. 1987;74(6):631-4.

PMID:3435787
Abstract

Seric values have been evaluated in 24 patients receiving high doses of etoposide. In 6 patients, CNS value was evaluated simultaneously. After 2 perfusions with 250 mg/m2 at 12 h interval, seric value is 35.3 micrograms/ml + 10.3, the value after 6 perfusions is 31.1 micrograms/ml + 6.5. The variation of CNS value observed from 0.08 to 0.49 micrograms/ml is 0.36 to 1.29% of the seric value; there is no positive correlation with seric value. Only one patient out of 6 has a partial response of CNS metastases.

摘要

已对24例接受高剂量依托泊苷治疗的患者的血清值进行了评估。其中6例患者同时评估了中枢神经系统值。在以12小时间隔进行2次250mg/m²的灌注后,血清值为35.3微克/毫升±10.3,6次灌注后的血清值为31.1微克/毫升±6.5。观察到的中枢神经系统值从0.08微克/毫升至0.49微克/毫升的变化为血清值的0.36%至1.29%;与血清值无正相关。6例患者中只有1例对中枢神经系统转移有部分反应。

相似文献

1
[Serum and cerebrospinal fluid levels after high dose of etoposide administrated intravenously].大剂量静脉注射依托泊苷后的血清和脑脊液水平
Bull Cancer. 1987;74(6):631-4.
2
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.给予癌症患者大剂量依托泊苷(VP-16-213)的药代动力学。
Cancer Res. 1984 Jan;44(1):379-82.
3
Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.
J Clin Oncol. 1984 Mar;2(3):215-20. doi: 10.1200/JCO.1984.2.3.215.
4
Phase I study of high-dose etoposide phosphate in man.高剂量磷酸依托泊苷在人体中的I期研究。
Bone Marrow Transplant. 1996 Nov;18(5):851-6.
5
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.米托坦联合依托泊苷、阿霉素和顺铂治疗晚期肾上腺皮质癌。意大利肾上腺癌研究小组。
Cancer. 1998 Nov 15;83(10):2194-200.
6
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.顺铂和依托泊苷一线化疗用于乳腺癌、非小细胞肺癌或恶性黑色素瘤脑转移患者:一项前瞻性研究。
Cancer. 1999 Apr 1;85(7):1599-605.
7
Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.依托泊苷经静脉和口服给药后在人恶性脑肿瘤中的渗透情况。
Cancer Chemother Pharmacol. 1992;29(5):339-42. doi: 10.1007/BF00686001.
8
Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.以异环磷酰胺和依托泊苷为基础的化疗作为预后不良淋巴瘤的挽救和动员方案。
Eur J Haematol Suppl. 2001 Jul;64:21-7.
9
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.缺氧细胞增敏剂依他硝唑与异环磷酰胺、卡铂、依托泊苷联合应用及自体造血干细胞支持下的剂量递增研究。
Clin Cancer Res. 1998 Jun;4(6):1443-9.
10
A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.拓扑异构酶I和II抑制剂拓扑替康与依托泊苷序贯给药的I期及转化研究
Clin Cancer Res. 1998 Jun;4(6):1459-67.

引用本文的文献

1
Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.依托泊苷经静脉和口服给药后在人恶性脑肿瘤中的渗透情况。
Cancer Chemother Pharmacol. 1992;29(5):339-42. doi: 10.1007/BF00686001.